We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-13.9%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$8.16B
AUM Growth
+$248M
Cap. Flow
+$1.5B
Cap. Flow %
18.35%
Top 10 Hldgs %
14.12%
Holding
2,786
New
644
Increased
646
Reduced
549
Closed
902

Top Buys

Rank Stock Value
1
ETR icon
Entergy
ETR
+$79.1M
2
DTE icon
DTE Energy
DTE
+$73.2M
3
FDX icon
FedEx
FDX
+$48.6M
4
MPC icon
Marathon Petroleum
MPC
+$47.5M
5
CMS icon
CMS Energy
CMS
+$45.3M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$75.8M
2
XOM icon
ExxonMobil
XOM
+$62M
3
LIN icon
Linde
LIN
+$49.9M
4
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$38.6M
5
EXPE icon
Expedia Group
EXPE
+$29.7M

Sector Composition

Rank Sector Weight
1 Industrials 14.24%
2 Technology 13.54%
3 Utilities 9.55%
4 Financials 8.68%
5 Healthcare 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGX icon
1851
Invesco Preferred ETF
PGX
$3.73B
$20K ﹤0.01%
1,656
-498,344
-100% -$6.27M
ZYNE
1852
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$20K ﹤0.01%
17,929
-6,796
-27% -$8.65K
BZFD icon
1853
BuzzFeed
BZFD
$94.2M
$19K ﹤0.01%
3,011
-6,775
-69% -$102K
CLSD
1854
DELISTED
Clearside Biomedical
CLSD
$19K ﹤0.01%
+852
New +$20.7K
CORZ
1855
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$18K ﹤0.01%
11,889
-84,512
-88% -$388K
DCH
1856
Dauch Corp
DCH
$1.53B
$16K ﹤0.01%
2,074
-99,328
-98% -$747K
EXPE icon
1857
Expedia Group
EXPE
$40.7B
$16K ﹤0.01%
164
-209,432
-100% -$29.7M
FWONA icon
1858
Liberty Media Series A
FWONA
$24.6B
$15K ﹤0.01%
274
-531
-66% -$29.4K
ROIVW
1859
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$15K ﹤0.01%
24,563
ITA icon
1860
iShares US Aerospace & Defense ETF
ITA
$14B
$13K ﹤0.01%
+127
New +$13.1K
SPRU icon
1861
Spruce Power Holding Corp
SPRU
$37M
$13K ﹤0.01%
+1,466
New +$16.9K
UXIN
1862
Uxin Ltd
UXIN
$251M
$13K ﹤0.01%
+304
New +$18.2K
EIRL icon
1863
iShares MSCI Ireland ETF
EIRL
$79.9M
$12K ﹤0.01%
309
+121
+64% +$5.48K
RTB
1864
RTB Digital
RTB
$172M
$12K ﹤0.01%
+31
New +$29.9K
IYZ icon
1865
iShares US Telecommunications ETF
IYZ
$1.27B
$11K ﹤0.01%
+420
New +$11.4K
PARAA
1866
DELISTED
Paramount Global Class A
PARAA
$11K ﹤0.01%
+393
New +$12.9K
RUBY
1867
DELISTED
Rubius Therapeutics, Inc
RUBY
$9K ﹤0.01%
10,061
-8,659
-46% -$14.5K
TOON icon
1868
Kartoon Studios
TOON
$40.2M
$8K ﹤0.01%
+1,102
New +$8.43K
IGC icon
1869
IGC Pharma
IGC
$31.1M
$7K ﹤0.01%
+13,049
New +$8.23K
UAVS icon
1870
AgEagle Aerial Systems
UAVS
$67.9M
$7K ﹤0.01%
+11
New +$9.14K
THD icon
1871
iShares MSCI Thailand ETF
THD
$356M
$3K ﹤0.01%
+42
New +$3.09K
HHLA.WS
1872
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$3K ﹤0.01%
16,100
BF.A icon
1873
Brown-Forman Class A
BF.A
$13.5B
$2K ﹤0.01%
25
NAACW
1874
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
$2K ﹤0.01%
+15,780
New +$3.85K
A icon
1875
Agilent Technologies
A
$43.3B
-64,129
Closed -$8.49M

Similar funds

Michael Gelband's Q2 2022 Portfolio in Review

As of Q2 2022, Michael Gelband held 2,786 positions worth $8.16B, up 3.1% from $7.91B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Michael Gelband deployed $1.5B of net new capital in Q2 2022, opening 644 new positions and adding to 646 existing holdings. Its largest new stake was Marathon Petroleum: 508,082 shares worth $41.8M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Utilities.

On the sell side, the largest reduction was AT&T, an estimated $75.8M trimmed.

  • Michael Gelband's largest Q2 2022 buy was Marathon Petroleum: 508,082 shares worth $41.8M.
  • Michael Gelband added most to Entergy in Q2 2022, an estimated $79.1M increase.
  • Michael Gelband's biggest Q2 2022 reduction was AT&T, cutting an estimated $75.8M.
  • Michael Gelband fully exited Linde in Q2 2022, selling an estimated $49.9M.
  • Michael Gelband's ten largest holdings make up 14% of its $8.16B portfolio in Q2 2022.
  • Michael Gelband opened 644 new positions and closed 902 in Q2 2022.
  • Michael Gelband's portfolio value rose 3.1% quarter-over-quarter to $8.16B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.